These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 19100320

  • 1. Particle size control of poly(dl-lactide-co-glycolide) nanospheres for sterile applications.
    Tsukada Y, Hara K, Bando Y, Huang CC, Kousaka Y, Kawashima Y, Morishita R, Tsujimoto H.
    Int J Pharm; 2009 Mar 31; 370(1-2):196-201. PubMed ID: 19100320
    [Abstract] [Full Text] [Related]

  • 2. Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods.
    Kawashima Y, Yamamoto H, Takeuchi H, Hino T, Niwa T.
    Eur J Pharm Biopharm; 1998 Jan 31; 45(1):41-8. PubMed ID: 9689534
    [Abstract] [Full Text] [Related]

  • 3. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP, Quan DP, Liao KR, Tao Wang, Peng Xiang, Mai KC.
    J Biomater Appl; 2008 Jan 31; 22(4):353-71. PubMed ID: 17494965
    [Abstract] [Full Text] [Related]

  • 4. Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate.
    Yin J, Noda Y, Yotsuyanagi T.
    Int J Pharm; 2006 May 11; 314(1):46-55. PubMed ID: 16551494
    [Abstract] [Full Text] [Related]

  • 5. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S, Shi Y, Li L, Xu J, Schaper A, Kissel T.
    Eur J Pharm Biopharm; 2008 Feb 11; 68(2):214-23. PubMed ID: 17651954
    [Abstract] [Full Text] [Related]

  • 6. Adriamycin release from self-assembling nanospheres of poly(DL-lactide-co-glycolide)-grafted pullulan.
    Jeong YI, Na HS, Oh JS, Choi KC, Song CE, Lee HC.
    Int J Pharm; 2006 Sep 28; 322(1-2):154-60. PubMed ID: 16891068
    [Abstract] [Full Text] [Related]

  • 7. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
    Doan TV, Olivier JC.
    Int J Pharm; 2009 Dec 01; 382(1-2):61-6. PubMed ID: 19682562
    [Abstract] [Full Text] [Related]

  • 8. Hybrid-modified poly(D,L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system.
    Tahara K, Furukawa S, Yamamoto H, Kawashima Y.
    Int J Pharm; 2010 Jun 15; 392(1-2):311-3. PubMed ID: 20347023
    [Abstract] [Full Text] [Related]

  • 9. Direct plasmid DNA encapsulation within PLGA nanospheres by single oil-in-water emulsion method.
    Mok H, Park TG.
    Eur J Pharm Biopharm; 2008 Jan 15; 68(1):105-11. PubMed ID: 17870446
    [Abstract] [Full Text] [Related]

  • 10. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
    Gasparini G, Kosvintsev SR, Stillwell MT, Holdich RG.
    Colloids Surf B Biointerfaces; 2008 Feb 15; 61(2):199-207. PubMed ID: 17919891
    [Abstract] [Full Text] [Related]

  • 11. Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique.
    Ito F, Fujimori H, Honnami H, Kawakami H, Kanamura K, Makino K.
    Colloids Surf B Biointerfaces; 2008 Oct 01; 66(1):65-70. PubMed ID: 18585903
    [Abstract] [Full Text] [Related]

  • 12. Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres.
    Takashima Y, Saito R, Nakajima A, Oda M, Kimura A, Kanazawa T, Okada H.
    Int J Pharm; 2007 Oct 01; 343(1-2):262-9. PubMed ID: 17628365
    [Abstract] [Full Text] [Related]

  • 13. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
    Mukerjee A, Vishwanatha JK.
    Anticancer Res; 2009 Oct 01; 29(10):3867-75. PubMed ID: 19846921
    [Abstract] [Full Text] [Related]

  • 14. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
    Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y.
    Int J Pharm; 2009 Dec 01; 382(1-2):198-204. PubMed ID: 19646519
    [Abstract] [Full Text] [Related]

  • 15. An innovative, quick and convenient labeling method for the investigation of pharmacological behavior and the metabolism of poly(DL-lactide-co-glycolide) nanospheres.
    Stevanović M, Maksin T, Petković J, Filipic M, Uskoković D.
    Nanotechnology; 2009 Aug 19; 20(33):335102. PubMed ID: 19636100
    [Abstract] [Full Text] [Related]

  • 16. Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (D,L-lactide-co-glycolide) nanospheres for gene delivery.
    Tahara K, Yamamoto H, Kawashima Y.
    Eur J Pharm Biopharm; 2010 Jun 19; 75(2):218-24. PubMed ID: 20332026
    [Abstract] [Full Text] [Related]

  • 17. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A, Siegel SJ, Winey KI.
    Int J Pharm; 2007 May 24; 336(2):367-75. PubMed ID: 17207944
    [Abstract] [Full Text] [Related]

  • 18. Effect of microfluidization parameters on the physical properties of PEG-PLGA nanoparticles prepared using high pressure microfluidization.
    Sani SN, Das NG, Das SK.
    J Microencapsul; 2009 Sep 24; 26(6):556-61. PubMed ID: 18946802
    [Abstract] [Full Text] [Related]

  • 19. Controlled assembly of poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres under ultrasonic irradiation.
    Jevtić M, Radulović A, Ignjatović N, Mitrić M, Uskoković D.
    Acta Biomater; 2009 Jan 24; 5(1):208-18. PubMed ID: 18753023
    [Abstract] [Full Text] [Related]

  • 20. Nanostructured microspheres produced by supercritical fluid extraction of emulsions.
    Della Porta G, Reverchon E.
    Biotechnol Bioeng; 2008 Aug 01; 100(5):1020-33. PubMed ID: 18383122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.